lobbying_activities: 2030438

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2030438	30383b92-2009-4d0f-92dc-8c251174d2bc	Q3	KOUNTOUPES DENHAM CARR & REID, LLC	320918	CVS HEALTH	2017	third_quarter	PHA	General education about the pharmacy benefit manager/pharmacy industry, including S.637, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.974 and H. R. 2212, The CREATES Act. Issues related to drug pricing such as S.771 and H.R. 1776, The Improving Access to Affordable Drugs Act. Issues related to opioid abuse.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2017-10-18T15:04:52.173000-04:00